Chemoinformaics analysis of 5.beta.-iodomethyl-1.beta.-isopropenyl-4.alpha.
| Molecular Weight | 332.269 | nRot | 2 |
| Heavy Atom Molecular Weight | 307.069 | nRig | 11 |
| Exact Molecular Weight | 332.1 | nRing | 2 |
| Solubility: LogS | -5.847 | nHRing | 0 |
| Solubility: LogP | 5.212 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 47.0698 |
| nHD | 0 | BPOL | 28.7602 |
| QED | 0.369 |
| Synth | 4.487 |
| Natural Product Likeliness | 2.32 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.016 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.665 |
| MDCK | 0.0000137 |
| BBB | 0.433 |
| PPB | 0.893225 |
| VDSS | 1.523 |
| FU | 0.167446 |
| CYP1A2-inh | 0.217 |
| CYP1A2-sub | 0.797 |
| CYP2c19-inh | 0.242 |
| CYP2c19-sub | 0.956 |
| CYP2c9-inh | 0.226 |
| CYP2c9-sub | 0.717 |
| CYP2d6-inh | 0.162 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.35 |
| CYP3a4-sub | 0.368 |
| CL | 8.258 |
| T12 | 0.099 |
| hERG | 0.004 |
| Ames | 0.028 |
| ROA | 0.172 |
| SkinSen | 0.162 |
| Carcinogencity | 0.121 |
| EI | 0.875 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.384 |
| Antiviral | Yes |
| Prediction | 0.913172 |